One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-147598
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 9 |
Affiliation: Queen Elizabeth II Health Sciences Centre, Open Health Systems Laboratory, The Ohio State University, University of California, San Diego, University College London, University College London Hospitals NHS Foundation Trust, Uppsala University Hospital, Ottawa Hospital, Hôpital de l'Enfant-Jésus, University of Amsterdam, Amsterdam University Medical Centers, Lille’s Cardiology Hospital, Cambridge University Hospitals NHS Foundation Trust, The University of Texas MD Anderson Cancer Center, Royal Marsden NHS Foundation Trust, Icahn School of Medicine at Mount Sinai, McGill University Health Centre, Tel Aviv University, Tel Aviv Sourasky Medical Center, Heidelberg University, Università della Svizzera italiana, Northwestern University, University of Maryland, Baltimore, University of Maryland Medical Center, The Christie NHS Foundation Trust, University of Manchester, UPMC Hillman Cancer Center, Instituto de Investigación Biomédica de Salamanca, Universität Innsbruck, Innsbruck Medical University, Université Paris Cité, Hôpital Saint-Louis, Moffitt Cancer Center
Patient-Reported Outcomes in a Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard of Care Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma (ZUMA-7)
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
